1. Tyne Tees

'Unaffordable' breast cancer drug could become unavilable

A new breast cancer drug which extends women's lives by almost six months could be blocked from routine NHS access because it is too expensive, a health watchdog says.

View all 3 updates ›

Rejected drug described as "cruise missile" for cancer

Kadcyla, a drug that can offer some women with advanced breast cancer nearly six months of extra life, which was trialled here in the North East, has for now been rejected for use in the NHS, because of its high cost.

A Newcastle doctor whose patients have been involved in the clinical trials is disappointed by the decision.

Dr Mark Verrill, from the Freeman Hospital, say the drug is revolutionary.

More top news